欢迎来到MSDS查询网--MSDS安全网
当前位置:MSDS安全网 -> 英文MSDS查询 -> KIMBERLY-CLARK FLUFF PULP MSDS报告
免费英文MSDS查询网站--MSDS安全网
KIMBERLY-CLARK FLUFF PULP MSDS报告[下载][中文版]

Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

KIMBERLY-CLARK FLUFF PULP

NFPA

Flammability 1
Toxicity 2
Body Contact 1
Reactivity 0
Chronic 2
SCALE: Min/Nil=0 Low=1 Moderate=2 High=3 Extreme=4

PRODUCT USE

Used in the manufacture of tissues, diapers and towelling.

SYNONYMS

"tissue towelling diaper pulp board"

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  Considered an unlikely route of entry in commercial/industrial environments.  Large doses of cellulose may be administered orally as non-nutritive bulk. Doses of up to 30 g/day can be tolerated as bulk laxative. Extremely large oral doses may produce gastrointestinal disturbances.  

EYE

  The dust may produce eye discomfort causing smarting, pain and redness.  

SKIN

  Not applicable.  

INHALED

  Inhalation may produce health damage*.  Persons with impaired respiratory function, airway diseases and conditions such as emphysema or chronic bronchitis, may incur further disability if excessive concentrations of particulate are inhaled.  Cellulose, after a single intratracheal dose (15 mg per animal) brought about fibrosing granulomatous bronchioloalveolitis and an increase of IgA production in the bronchioalveolar lavage. Fibrosing alveolitis showed moderate progression as a function of time. Injury of Type I pneumocytes and incomplete repair of Type II pneumocytes were detected. The damage of alveolar epithelium initiated and activated a series of processes that led to definite pulmonary alterations and pulmonary fibrosis leading to disintegration of the alveolo-capillary morphological functional unit.  Tatrai, E. et al: Journal of Applied Toxicology; 16(2) 129-135 (1996)Some health effects associated with wood, cotton, flax, jute and hemp particles or fibres are not attributable to cellulose content but to other substances and/or impurities.  

CHRONIC HEALTH EFFECTS

  Principal routes of exposure are by accidental skin and eye contact andinhalation of generated dusts.  Inhalation studies indicate that cellulose fibres may be fibrogenic; this finding continues to be the subject of extensive research. Cellulose is not considered an inert substance because:  ·  in rats, it causes granulomatous fibrosing alveolitis at the end of the third month after exposure,  · in rats there was an increase in the secretion of plasminogen activator and interleukin 1 as well as the release of lactate dehydrogenase from macrophages, in a manner similar to asbestos,  · there were increases in the incidence of obstructive lung diseases and bronchial asthma in humans at work and in the residential environment where exposure to cellulose was common,  · the substance may induce free radical production in human leucocytes.  Cotton dust disease, "byssinosis", is well known among cotton mill workers. Cotton dust consists largely of cellulose fibre. Exposure to two components of the total dust, the "respirable" and "medium" fraction correlated significantly with the prevalence of respiratory symptoms. Inhalation exposure to a concentration of 0.3 to 0.4 mg/m3 of "fly-  free" dust results in a 20% occurrence of byssinosis. "Fly-free" dust is the sum of respirable and medium-length fibres. At 0.46 mg/m3, Grade II byssinosis occurs. A byssinosis (all grades) prevalence of 20%, at 0.3 mg/m3 occurs when the fibre length is less than 15 um (aerodynamic equivalent diameter). Byssinosis is not caused by mechanical irritation but by reactions caused by pharmacologically active substances producing oedema or contraction of the smooth musculature of the airways. The causative agent is suspected to be an endotoxin, in turn, thought to be a cell wall component of bacteria found in cotton. Symptoms of byssinosis include chest tightness, wheezing and dyspnoea. Symptoms usually appear after an absence from work and may subside after 2-days of exposure. As the disease progresses, symptoms may persist for longer periods until they are constant. The individual may eventually exhibit chronic bronchitis and emphysema. Increased physical exertion may produce shortness of breath.  
【温馨提示】 MSDS安全网为了能让广大网友得到更好的服务,杜绝不法人员盗用本站共享资源,最终决定隐藏部分核心资源内容,只供注册会员查看; 本站会员采用微信账号登录/免费注册机制,登录成功后即可免费查看和下载本站所有资源!谢谢支持! 微信账号登录 注意:微信账号登录成功后,若页面没有刷新,请按F5刷新本页面!
在线下载 KIMBERLY-CLARK FLUFF PULP MSDS报告